Journals / İstanbul Kanuni Sultan Süleyman Tıp Dergisi / 2021 / Cilt: 13 - Sayı: 3

Wilms Tümörü: Tek Merkezin 32 Yıllık Deneyimleri ile Güncel Literatürün Gözden Geçirilmesi

Pages
207–212
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Future efforts in the treatment of WT should be to create national and international integrated data screening indexes in order to increase recovery, reduce chemotherapy toxicity and contribute to innovations in treatment, especially in high-risk cases, as in our series.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Wilms Tumor (WT) is the most common renal tumor of childhood, usually seen between the ages of 2-4 years.
📊
Key Findings & Data:The survival rate is reported as 90% in non-metastatic cases and 75% in metastatic cases.
💡
Conclusion & Impact:Conclusion: Future efforts in the treatment of WT should be to create national and international integrated data screening indexes in order to increase recovery, reduce chemotherapy toxicity and contribute to innovations in treatment, especially in high-risk cases, as in our series.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Wilms Tumor (WT) is the most common renal tumor of childhood, usually seen between the ages of 2-4 years. The survival rate is reported as 90% in non-metastatic cases and 75% in metastatic cases. In the study, it was aimed to review the current literature by presenting 32 years of WT experiences of a single center. Method: The files of 70 patients who underwent WT surgery in our Pediatric Surgery clinic between January 1988 and December 2019 were retrospectively reviewed. Results: Sixty-two of the 70 cases were unilateral and 8 were bilateral. 33 (53.2%) of unilateral cases were female, 29 (46.7%) of them were male, 5 (62.5%) of bilateral cases were female and 3 (37.5%) of them were male. The mean age was determined as 33.6 months (8-62) in unilateral cases and 25.4 months (12-54) in bilateral cases. WAGR Syndrome was found in one case. 5 of the cases were Stage I, 22 were Stage II, 19 were Stage III, 16 were Stage IV and 8 were Stage V. The most common metastasis was detected in the lung at the rate of 56% (n=9/16). While anaplasia was judged histopathologically in 12 (17.1%) of the cases, recurrence was detected in 10 (14.2%) cases. One case died peroperatively and 13 patients died during follow-up. 8 (61.5%) of those who were lost were undesirable in histopathology including anaplasia. The survival rate in our series was determined as 91% in positive cases and 33% in unfavorable cases. Conclusion: Future efforts in the treatment of WT should be to create national and international integrated data screening indexes in order to increase recovery, reduce chemotherapy toxicity and contribute to innovations in treatment, especially in high-risk cases, as in our series.

Özet

Amaç: Wilms tümörü (WT) çocukluk çağının en sık renal tümörü olup genellikle 2-4 yaş arasında görülmektedir. Asıl tedavisi cerrahi olan WT olgularında sağ kalım oranı metastatik olmayanlarda %90, metastatik olanlarda %75 olarak bildirilmektedir. Çalışmada, tek merkezin 32 yıllık WT deneyimlerinin sunulması ile güncel literatürün gözden geçirilmesi amaçlandı. Yöntem: Ocak 1988 - Aralık 2019 arasında çocuk cerrahisi kliniğimizde WT nedeniyle ameliyat edilen 70 olgunun dosyaları geri dönük olarak incelendi. Bulgular: Yetmiş olgunun 62’si tek, 8’i çift taraflı idi. Tek taraflı olguların 33’ü (%53,2) kız, 29’u (%46,7) erkek, çift taraflı olguların 5’i (%62,5) kız, 3’ü (%37,5) erkek idi. Tek taraflı olgularda ortalama yaş 33.6 ay (8-62), çift taraflı olgularda 25.4 ay (12-54) olarak belirlendi. Bir olguda WAGR Sendromu, bir olguda at nalı böbrek saptandı. Olguların 5’i Evre 1, 22’si Evre 2, 19’u Evre 3, 16’sı Evre 4 ve 8’i Evre 5 idi. En sık metastaz %56 (n = 9/16) oranında akciğerde saptandı. Cerrahi olarak tek taraflı olgulara nefroüreterektomi, çift taraflı olgulara nefron koruyucu cerrahi uygulandı. Olguların 12’sinde (%17,1) histopatolojik olarak anaplazi belirlenirken 10 (%14,2) olguda nüks saptandı. 1 olgu peroperatif, 13 olgu ise takipte kaybedildi. Kaybedilenlerin 8’i (%61,5) anaplazi içeren unfavorable histopatolojide idi. Serimizde sağ kalım oranı, favorable olgularda %91, unfavorable olgularda ise %33 olarak belirlendi. Sonuç: WT tedavisinde gelecekteki çabalar, bizim serimizde olduğu gibi özellikle yüksek riskli olgularda iyileşmeyi artırmak, kemoterapi toksisitesini azaltmak ve tedavide yeniliklere katkı sağlamak amacıyla ulusal ve uluslararası entegrasyonlu veri tarama indeksleri oluşturmak olmalıdır.

🔖

Cite This Article

KARAASLAN, B., ÖZAYDIN, S. (2022). Wilms Tümörü: Tek Merkezin 32 Yıllık Deneyimleri ile Güncel Literatürün Gözden Geçirilmesi. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, Cilt: 13 - Sayı: 3, 207–212. https://ajindex.com/articles/550921

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Szychot E, Apps J, Pritchard-Jones K. Wilms' tumor: biology, diagnosis and treatment. Transl Pediatr. 2014;3:12-24. doi: 10.3978/j.issn.2224- 4336.2014.01.09
  2. Davidoff AM. Wilms' tumor. Curr Opin Pediatr. 2010;22:386. doi: 10.1097/ MOP.0b013e32832b323a
  3. Gleason JM, Lorenzo AJ, Bowlin PR, Koyle MA. Innovations in the management of Wilms' tumor. Ther Adv Urol. 2014;6:165-76. doi: 10.1177/1756287214528023
  4. Deng C, Dai R, Li X, Liu F. Genetic variation frequencies in Wilms' tumor: a meta-analysis and systematic review. Cancer Sci. 2016;107:690-9. doi: 10.1111/cas.12910
  5. Phelps HM, Kaviany S, Borinstein SC, Lovvorn HN 3rd. Biological drivers of wilms tumor prognosis and treatment. Children (Basel). 2018;5:145. doi: 10.3390/children5110145 6. Charlton J, Irtan S, Bergeron C, Pritchard-Jones K. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med. 2017;19:e8. doi: 10.1017/erm.2017.8
  6. Murphy AJ, Davidoff AM. Bilateral Wilms tumor: a surgical perspective. Children (Basel). 2018;5:134. doi: 10.3390/children5100134
  7. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67:437-47. doi: 10.1016/0092-8674(91)90194-4 9. Ohlsson R, Nyström A, Pfeifer-Ohlsson S, et al. IGF2 is parentally imprinted during human embryogenesis and in the BeckwithWiedemann syndrome. Nat Genet. 1993;4:94-7. doi: 10.1038/ng0593-94
  8. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990;60:509-20. doi: 10.1016/0092-8674(90)90601-a
  9. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-8. doi: 10.1038/343774a0 12. Grundy RG, Pritchard J, Baraitser M, Risdon A, Robards M. Perlman and Wiedemann-Beckwith syndromes: two distinct conditions associated with Wilms' tumour. Eur J Pediatr. 1992;151:895-8. doi: 10.1007/ BF01954125
  10. Astuti D, Morris MR, Cooper WN, et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet. 2012;44:277-84. doi: 10.1038/ng.1071
  11. Shamberger RC, Ritchey ML, Haase GM, et al. Intravascular extension of Wilms tumor. Ann Surg. 2001;234:116-21. doi: 10.1097/00000658- 200107000-00017
  12. Fukuda A, Isoda